Staff Collaborate Conference Room

Liang Wang, MD, PhD

Liang Wang, MD, PhD

Liang Wang, MD, PhD

Professor, Pathology & Laboratory Medicine and Microbiology & Immunology


  • Pathology & Laboratory Medicine

Contact Information

General Interests

Cancer Genetics and Biomarkers


BMed (MD), North China University of Science and Technology, China, 1980-1985
MSc, Cytogenetics, Zhengzhou University, China, 1985-1988
PhD, Cancer Genetics, Peking Union Medical College, China, 1992-1995


Liang Wang, MD, PhD, is a Professor of Pathology at the Medical College of Wisconsin. He is a member of MCW Cancer Center and a member of American Association for Cancer Research and American Society of Human Genetics.

Over the years, Dr. Wang’s research has been focused on genetics of human cancers, in particular, the prostate cancer. He has led a multi-disciplinary team from study design, sample collection to data generation and interpretation using a variety of genetic and genomic platforms. He has successfully performed various data analyses and laboratory tests leading to identification of candidate genes and genetic variants, with multiple peer-reviewed publications including Nature Genetics, Gastroenterology, American Journal of Human Genetics, Lancet Oncology, Cancer Research and European Urology.

Dr. Wang was an invited speaker in numerous Colleges and Universities. He has served as a reviewer for major funding agencies including both domestic (NIH and DOD) and international (Italian Ministry of Health). He received AACR Scholar-in-training award in 2004. Currently, his research is being supported by NIH and other funding agencies.

Research Interests

Research Description

Human genome/epigenome variations and cancers, focusing on biomarker study for personalized medicine through large scale RNA/DNA sequencing analysis.

  • Genetic susceptibility of human cancers including prostate, esophagus and lung cancers using eQTL-based gene mapping, systems biology-based network analysis and large scale case-control association study.
  • RNA/DNA biomarkers in human cancers including prostate, pancreas, colon and lung by testing blood/tissue DNA/RNAs in well-characterized patient populations using genomewide methylation, next-gen RNA/DNA sequencing and bioinformatics approaches.